CG
SBBP

Cutler Group’s Strongbridge Biopharma plc. SBBP Stock Holding History

Cutler Group’s Portfolio SBBP Stock Details SBBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-1,200
Closed -$4K – 5473
2020
Q2 		$4K Hold
1,200
– – ﹤0.01% 3537
2020
Q1 		$2K Buy
+1,200
New +$3.12K ﹤0.01% 3609
2019
Q3 		– Sell
-1,000
Closed -$3K – 4950
2019
Q2 		$3K Sell
1,000
-4,400
-81% -$16.2K ﹤0.01% 3468
2019
Q1 		$26K Buy
5,400
+1,000
+23% +$4.92K ﹤0.01% 1869
2018
Q4 		$19K Buy
+4,400
New +$21.5K ﹤0.01% 2161

Other funds holding SBBP

CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Cutler Group's SBBP Position: Q3 2020 in Review

Cutler Group sold out of Strongbridge Biopharma plc. (SBBP) in Q3 2020, closing a stake of 1,200 shares — an estimated $4K sold.

Cutler Group first reported a position in SBBP in Q4 2018 and held it in 5 quarters. The position peaked at $26K in Q1 2019. 77 funds tracked by Wall St. Rank hold SBBP as of Q3 2020.

  • Cutler Group reported no remaining Strongbridge Biopharma plc. position as of Q3 2020 after selling out during the quarter.
  • Cutler Group sold 1,200 Strongbridge Biopharma plc. shares in Q3 2020, an estimated $4K.
  • Cutler Group first reported a position in Strongbridge Biopharma plc. in Q4 2018 and held it in 5 quarters.
  • Cutler Group's Strongbridge Biopharma plc. position peaked at $26K in Q1 2019.
  • 77 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q3 2020.

Based on Cutler Group's 13F filing for Q3 2020, filed 27 Oct 2020.